Donovan Driscoll, PA
Surgical · Hyannis, MANPI 1700293206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Zimmer Biomet accounts for 70.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $396 and has fallen 58.1% since, to $166 in 2025.
Across 27 payments — averaging $48.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$911
- Novo Nordisk$124
- Smith+Nephew$111
- Stryker$73
- Endo Pharmaceuticals Inc.$39
- Johnson & Johnson$28
- plus $12 from 1 others
What the payments were for
- Food & beverage$1,297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 19 | $911 |
| Novo Nordisk | 1 | $124 |
| Smith+Nephew | 2 | $111 |
| Stryker | 1 | $73 |
| Endo Pharmaceuticals Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $28 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$124
How this compares
$1,297 in reported general payments places this provider in the 85th percentile of 312 surgical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 275 | $752 |
| Oxycodone Hcl | 219 | $706 |
| Prednisone | 62 | $241 |
| Tramadol Hcl | 90 | $235 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $137 |
| Diclofenac Sodium | 16 | $86 |
| Cyclobenzaprine Hcl | 26 | $83 |
| Methylprednisolone | 12 | $80 |
| Hydromorphone Hcl | 16 | $46 |
| Ibuprofen | 12 | $36 |
| Amoxicillin | 28 | $29 |
Paid to pharmacies, not to this prescriber.
Other surgical in Hyannis
- Kyle RickstadHyannis$3K
- Julie WinnHyannis$2K
- Trenton HilesHyannis$2K
- Jennifer MillerHyannis$1K
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
- Nicolas DesjardinsSomerville$10K
- Robert KenneyChestnut Hill$8K
- Michael LlewellynBoston$8K
- Anargyros SkaliotisNorth Dartmouth$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.